Co'Moon for Supporting Breast Cancer Patients on Adjuvant Endocrine Therapy
NCT ID: NCT05085678
Last Updated: 2023-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
77 participants
INTERVENTIONAL
2020-12-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of an eHealth Self-management Support Program for Persistent Pain After Breast Cancer Treatment
NCT06308029
Mitigating Toxicity by Electronic Health Portal-mediated Interactive Monitoring of Patient-reported Side Effects
NCT06424054
Role of Individualized Intervention(s) in Hormone-Receptor Positive Early-stage Breast Cancer
NCT03407768
Intervention to Improve Self-Care of Symptoms in Breast Cancer Survivors on Adjuvant Endocrine Therapy
NCT01738685
An Interactive Empowerment Tool for Breast Cancer Patients
NCT02312700
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Standard of care:
* a short overview of the physician on adjuvant endocrine therapy
* a brochure on adjuvant endocrine therapy
* a voluntary group session on adjuvant endocrine therapy
and a monthly questionnaire on the patient reported outcomes
No interventions assigned to this group
Intervention group
Standard care with the access of to the online tool Co'moon and a monthly questionnaire on patient reported outcomes.
The outcome of the questionnaires are summarized for the physician to discuss during the follow-up consultation.
Co'moon (online website to support women with AET)
The tool contains three parts:
1. e-learning based on the brochure on adjuvant endocrine therapy (AET) in the University Hospital Leuven,
2. serious game where patients are confronted with scenes of their daily life and motivational guidelines to stimulate their self-management,
3. a patient-reported-outcome questionnaire (PROMs), reported in the patient medical file.
The tool is designed to stimulate patients self-management of their menopausal AET-related complaints and to discuss them with their health care professionals .
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Co'moon (online website to support women with AET)
The tool contains three parts:
1. e-learning based on the brochure on adjuvant endocrine therapy (AET) in the University Hospital Leuven,
2. serious game where patients are confronted with scenes of their daily life and motivational guidelines to stimulate their self-management,
3. a patient-reported-outcome questionnaire (PROMs), reported in the patient medical file.
The tool is designed to stimulate patients self-management of their menopausal AET-related complaints and to discuss them with their health care professionals .
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Older than 18 years
* Speaking, understanding and writing Dutch fluently
* Mentally competent
* Recently underwent a operation for breast cancer (invasive or in situ)
* Takes AET for maximum two months
* Consultation planned within 4-5 month
* Home access of a computer with internet connection
* Contact with patient(s) included in the trial
Exclusion Criteria
* Metastatic disease
* Included in panels
* Member of the research team
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KU Leuven
OTHER
Universitaire Ziekenhuizen KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ines Nevelsteen, Phd
Role: PRINCIPAL_INVESTIGATOR
UZ Leuven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UZ Leuven campus Gasthuisberg
Leuven, Vlaams-Brabant, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
G0F9119N
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.